Full Text View
Tabular View
No Study Results Posted
Related Studies
Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)
This study is ongoing, but not recruiting participants.
Study NCT01322347   Information provided by Rockwell Medical Technologies, Inc.

First Received on March 22, 2011.   Last Updated on April 30, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Kidney Failure, Chronic
Renal Insufficiency
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
Soluble Ferric Pyrophosphate (SFP)
Standard dialysate
Additional drug interventions recognized in this trial
Iron
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Trace Elements
Sponsors listed in this trial
Rockwell Medical Technologies, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services